US HB7050 | 2025-2026 | 119th Congress
Status
Sponsorship: Moderate Partisan Bill (Republican 6-1)
Status: Introduced on January 14 2026 - 25% progression
Action: 2026-01-14 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 14 2026 - 25% progression
Action: 2026-01-14 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act with respect to homeopathic drug products, and for other purposes.
Title
Homeopathic Drug Product Safety, Quality, and Transparency Act
Sponsors
| Rep. Pete Sessions [R-TX] | Rep. Mike Kennedy [R-UT] | Rep. Jonathan Jackson [D-IL] | Rep. Burgess Owens [R-UT] |
| Rep. Cory Mills [R-FL] | Rep. Paul Gosar [R-AZ] | Rep. Michael Cloud [R-TX] |
History
| Date | Chamber | Action |
|---|---|---|
| 2026-01-14 | House | Referred to the House Committee on Energy and Commerce. |
| 2026-01-14 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/119th-congress/house-bill/7050/all-info |
| Text | https://www.congress.gov/119/bills/hr7050/BILLS-119hr7050ih.pdf |
